Anticholinergic drugs for COPD

April 2011
Internal Medicine Alert;4/15/2011 Pharmacology Watch, p1
The article reports that a new study in the New England Journal of Medicine states that anticholinergic drugs should be the first-line agents for preventing exacerbations in patients with chronic obstructive pulmonary disease (COPD).


Related Articles

  • Long-Term Azithromycin for Prophylaxis of COPD Exacerbations. Kuritzky, Louis // OB/GYN Clinical Alert;Nov2011 Clinical Briefs in Primary, p22 

    The article discusses research by R. K. Albert et al, published in a 2011 issue of the "New England Journal of Medicine" on the association between azithromycin prophylaxis and prolongation of time to first chronic obstructive pulmonary disease, acute exacerbations (AECOPD).

  • The POET-COPD(r) Study Results Demonstrate Superiority of Spiriva(r) (tiotropium) over Long-Acting Beta Agonist Salmeterol in Reducing the Risk for COPD Exacerbations.  // Biomedical Market Newsletter;4/30/2011, p600 

    The article reports on the results of the study "Prevention of Exacerbations with Tiotropium in Chronic Obstructive Pulmonary Disease (POET-COPD)" published by the "New England Journal of Medicine" in Germany and New York City. The study shows the superiority of spiriva over long-acting beta...

  • Heart Problems Directly Related to Impaired Lung Function.  // Pulmonary Reviews;Feb2010, Vol. 15 Issue 2, p10 

    The article presents the first study showing the link between heart function and mild chronic obstructive pulmonary disease (COPD), reported by investigators from Columbia University Medical Center in New York City. The research, published in the January 21, 2010 issue of "New England Journal of...

  • Steroids of Limited Benefit for Exacerbations of COPD. Kirchner, Jeffrey T. // American Family Physician;12/1/1999, Vol. 60 Issue 9, p2654 

    Presents an abstract of the study `Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease,' by D.E. Niewoehner et al., which appeared on the June 24, 1999 issue of the `New England Journal of Medicine.'

  • Tiotropium beats LABA in COPD. Swan, David // Pulse;9/26/2012, Vol. 72 Issue 31, p14 

    The article presents a study according to which Tiotropium, an anticholinergic bronchodilator is more effective than a long-acting beta- agonist in preventing chronic obstructive pulmonary disease (COPD).

  • Which Inhaler Combination is Best for COPD Treatment? Elliott, William T. // Infectious Disease Alert;Apr2007, Vol. 26 Issue 7, p1 

    This article focuses on two studies that investigated the effects of various inhaler combinations on outcomes in patients with chronic obstructive pulmonary disease (COPD). The studies appeared in the February 22, 2007 issue of the "New England Journal of Medicine" and in the "Annals of Internal...

  • SHORT CUTS. Tonks, Alison // BMJ: British Medical Journal (International Edition);3/3/2007, Vol. 334 Issue 7591, p448 

    This article focuses on news in medicine from other scholarly periodicals. An article in the "Annals of Internal Medicine" reports that heparin acts as a preventative against pulmonary embolus in medical inpatients. An article in the "New England Journal of Medicine" reports that, while...

  • MONTELUKAST FOR MILD AND EXERCISE-INDUCED ASTHMA. Adelman, Alan // Journal of Family Practice;Nov1998, Vol. 47 Issue 5, p335 

    This article discusses research done on the effectiveness of Montelukast in treating mild asthma and exercise-induced bronchoconstriction. It references a study by J. A. Leff and colleagues in a 1998 issue of the "New England Journal of Medicine." Several possible therapies for exercise-induced...

  • Inhaled Long-Acting β-Agonists Versus Anticholinergics in Older Patients With Chronic Obstructive Pulmonary Disease. Fabbri, Leonardo M.; Vogelmeier, Claus; Rabe, Klaus F.; Stanbrook, Matthew B.; Gershon, Andrea // Annals of Internal Medicine;10/18/2011, Vol. 155 Issue 8, p561 

    A letter to the editor is presented in response to the article "Comparison of inhaled long-acting β–agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study," by A. Gershon and colleagues in an issue of 2011 and a response...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics